84 results match your criteria: "centre d'addictovigilance[Affiliation]"
Pharmacoepidemiol Drug Saf
November 2018
Equipe de Pharmacoépidémiologie, UMR 1027 Inserm-Université Paul Sabatier Toulouse III, Toulouse, France.
Purpose: The increasing trend of diversion of nonprescription drugs (NPDs) by adolescents or young adults is worrying. We implemented this pilot study before a national investigation to identify requests for suspected recreational use of psychoactive drugs made by young subjects to community pharmacies.
Methods: Thirty-eight French community pharmacies were asked to complete questionnaire (with age, gender of subjects; name, form, quantity of drugs) for each suspect request formulated by subjects under 26.
Therapie
June 2019
Centre d'addictovigilance, service de pharmacologie médicale, CHU de Bordeaux, 33000 Bordeaux, France; Inserm U1219, Bordeaux population health, équipe pharmacoépidémiologie, 33000 Bordeaux, France.
Addictovigilance in the French Public Health Code, in the section related to poisonous substances, refers to a monitoring system developed since 1990: control of psychoactive substances and products, with medicinal use or not, was completed by a specific system focused on evaluation and information on pharmacodependance in 1999. The French medicines agency (Agence du médicament) created in 1993 was involved in this monitoring system; pharmacodependance evaluation was added by law to the missions of the agencies that followed: the Agence française de sécurité sanitaire des produits de santé missions (AFSSAPS, 1998) and the Agence nationale de sécurité du médicament et des produits de santé (ANSM, 2011). "Addictovigilance" first appears in French Law in 2017 whereas it was used by pharmacodependance centers and AFSSAPS since 2007.
View Article and Find Full Text PDFTherapie
December 2018
Département de pharmacologie médicale et toxicologie, centre d'addictovigilance, hôpital Lapeyronie, centre hospitalier universitaire, 191, avenue du Doyen-Gaston-Giraud, 34295 Montpellier cedex 5, France. Electronic address:
Introduction: Due to the increase of hospitalization at emergency department (ED) related to psychoactive substances use (PSU), the addictovigilance center of Montpellier has been integrated into the URGEIM program for the detection of iatrogenic events at the ED. The objective of the present work was to analyze spontaneous reports (SR) collected via the URGEIM program.
Methods: Analysis of spontaneous reports related to PSU at the ED of the Montpellier University Hospital, collected through the URGEIM program, between January 2014 and December 2016.
Fundam Clin Pharmacol
December 2018
Département de Pharmacologie Médicale et Toxicologie, Centre d'Addictovigilance, CHRU de Montpellier, 34294, Montpellier Cedex, France.
Ephenidine, diphenidine, and methoxphenidine belong to the family of diarylethylamines that are psychoactive substances derived from lefetamine (N, N-di-methyl-1,2-diphenylethylamine, also called L-SPA). These dissociative anesthetic compounds act as potent and selective N-methyl-d-aspartate receptor antagonists and were recently classified as narcotic drugs in France. The available data suggest a significant risk of psychic and somatic complications.
View Article and Find Full Text PDFTherapie
October 2018
Inserm U1219, service de pharmacologie médicale, centre d'addictovigilance de Bordeaux, CHU de Bordeaux, 33076 Bordeaux cedex, France.
Introduction: The government plan for the fight against drugs and addictive behaviors 2013-2017 includes several actions concerning French overseas territories, in particular to strengthen information on drug addiction. The Interministerial mission for combating drugs and addictive behaviors (MILD&CA) has commissioned the Bordeaux addictovigilance center to strengthen exchanges on addictovigilance with Réunion Island and Mayotte and to make an inventory of problematic drug use in these two French departments of Indian Ocean.
Method: Two pharmacologists went on an assignment 4.
Fundam Clin Pharmacol
October 2018
Centre d'Addictovigilance, Service de Pharmacologie Médicale, CHU de Bordeaux, F-33000, Bordeaux, France.
In France, prescription of narcotics must be written on a tamper-resistant prescription form with specific technical particularities. Dosage and daily dose of medicines shall be written out entirely in letters. These prescription forms are also mandatory for buprenorphine, clorazepate, clonazepam, tianeptine, buccal midazolam and zolpidem owing to traffic, abuse or diversion.
View Article and Find Full Text PDFBr J Clin Pharmacol
June 2018
Service de pharmacologie clinique et pharmacovigilance, CNRS, CEIP - addictovigilance PACA Corse, INSERM 1106, Institut des neurosciences des systemes, CHU Timone, Assistance Publique-Hôpitaux de Marseille, Aix-Marseille université, 13385, Marseille, France.
Aim: The aim of the present study was to characterize patterns of use of methylphenidate (MPH), a prescription stimulant medication recommended in the treatment of attention deficit hyperactivity disorder (ADHD) and of narcolepsy, in France, both in children and adults, over a 3-year period.
Methods: Using the French General Health Insurance database, limited to two areas covering approximately 4 million individuals, we made up a cohort of incident MPH users between July 2010 and June 2013. Splitting them into distinct age groups (18-24, 25-49 and ≥50 years of age for adults and <6, 6-11 and 12-17 years of age for children), we established the characteristics of these populations at MPH initiation and during follow-up according to the duration of treatment, quantities dispensed and coprescription with central nervous system (CNS) drugs.
Addict Behav
March 2018
Laboratoire de technologies pharmaceutiques industrielles (LTPIB), Univ. Bordeaux, F-33000 Bordeaux, France.
Background: Parachuting, also called bombing, is a way to ingest psychoactive substances wrapped into cigarette paper, toilet paper, etc. There is little data describing parachuting in terms of substances use, context of use and, most importantly, the motivations for using such wrappers, although some authors hypothesized that parachute could be used for pharmacokinetic reason. However, inconsistently, some authors report that parachutes are used for sustained-release whereas others report that users are looking for an immediate effect.
View Article and Find Full Text PDFJ Clin Psychopharmacol
December 2017
From the *Département de Pharmacologie Médicale et Toxicologie, Centre d'Addictovigilance, †Unité de Recherche Clinique et Epidémiologique, Département de l'Information Médicale, and ‡Département d'Addictologie, Médecine Interne, Centre Hospitalier Universitaire Montpellier, Montpellier, France.
Purpose: The objective of this cross-sectional study was to describe and estimate the prevalence of antipsychotics (AP) in a cohort of addicted patients, and to compare the profiles of addictive patients receiving AP or not.
Methods: We included all adult patients seen at the addiction care center of Montpellier University Hospital, between January 1, 2015, and March 31, 2015. Demographic, clinical, and therapeutic data were collected from the patients' medical records.
Rev Med Interne
January 2018
Unité transversale de traitement des infections, hôpital Henri Mondor, AP - HP, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil cedex, France.
Fundam Clin Pharmacol
October 2017
Centre Régional de Pharmacovigilance de Lorraine, Laboratoire de Pharmacologie Clinique et de Toxicologie, CHRU de Nancy, Hôpital Central, 29 avenue du Maréchal de Lattre de Tassigny, CO 60034, 54035, Nancy cedex, France.
Opioid antagonists such as naltrexone and nalmefene are used in drug therapy for alcoholism. Nalmefene, approved in Europe in February 2013 for the reduction of alcohol consumption, is used in patients with alcohol dependence. We report 11 cases of opioid withdrawal syndrome after a single dose of nalmefene in patients usually treated with methadone, buprenorphine, but also with fentanyl or loperamide.
View Article and Find Full Text PDFPharmacoepidemiol Drug Saf
May 2017
UMR Inserm 1027, Université Toulouse III, Toulouse, France.
Purpose: Drugs administered to hospitalized patients are not available within almost all health insurance databases. However, this unobservable exposure time bias is very rarely taken into account in pharmacoepidemiology. The objective was to model unobservable periods due to hospitalization and to assess their impact on risk estimates in the context of the association between benzodiazepines and mortality.
View Article and Find Full Text PDFTherapie
June 2017
Centre d'addictovigilance CEIP-A de Poitiers, service de pharmacologie clinique et vigilances, Pavillon R.-Le-Blaye, CHU de Poitiers, rue de la Milétrie, BP 577, 86021 Poitiers, France.
Fundam Clin Pharmacol
February 2017
CNRS, INT, Institut de Neurosciences Timone, APHM, Service de Pharmacologie Clinique, Centre d'Addictovigilance Paca Corse, Aix Marseille Université, F-13005, Marseille, France.
Addiction to illicit substances or medicines is influenced by cultural, religious, ethnic factors as well as local availability. The purpose of this study was to evaluate the profile of drug users and characteristics of the psychoactive substances used in French overseas territories, using data from the OPPIDUM survey. OPPIDUM is an annual, nationwide, multicentric, cross-sectional study based on specialized care centres that included subjects presenting a drug addiction or under opiate maintenance treatment.
View Article and Find Full Text PDFTherapie
December 2016
Département de pharmacologie clinique, centre d'addictovigilance, centre hospitalier universitaire, 44093 Nantes, France.
The use of psychoactive substances, whether occasional or regular, can induce a large number of clinical and/or biological complications. These complications may be related to the effects of the active substance itself and/or adulterants, but also to the modalities for use (administrations route, contexts of use). The detection and evaluation of these potentially severe complications are a public health issue.
View Article and Find Full Text PDFJ Anal Toxicol
November 2016
Service de pharmacologie médicale, laboratoire de pharmacologie-toxicologie, CHU Bordeaux
Use of methiopropamine (MPA), a synthetic metamfetamine analog, has been detected since 2011 in Europe, but there is limited information on its acute toxicity. A 30-year-old man was admitted to the emergency department in a confused state, with paranoid delusion, auditory and visual hallucinatory experiences, and incoherent speech following the use of "synthacaine" (a slang term derived from "synthetic" and "cocaine"). Toxicological screening for pharmaceuticals and drugs of abuse by liquid chromatography-diode-array detector, gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry (LC-MS-MS) detected MPA, which was subsequently quantified by a specific LC-MS-MS method.
View Article and Find Full Text PDFTherapie
December 2016
Service de pharmacologie, centre d'addictovigilance de Caen, CHU Côte de Nacre, 14033 Caen cedex 09, France. Electronic address:
Methylenedioxymethamphetamine (MDMA), the active compound of ecstasy, has been used for several years, especially by young adults to benefit of psychostimulant properties. By raising the level of neuromodulators in the synapsis, MDMA can cause psychiatric and physical injuries. After reduced supplies in 2009 (number of ecstasy seizures equal to 10 percent of those recorded in 2002), judicial authorities now observed an increased availability (a half more part of seizures in 2012 than 2010).
View Article and Find Full Text PDFTherapie
October 2016
Centre d'addictovigilance d'Île-de-France, Centre GHU Lariboisière-Fernand-Widal, 200, rue du Faubourg-Saint-Denis, 75010 Paris, France.
The "SLAM" phenomenon is an increasingly popular practice, in Paris and London gay scene, defined by 3 characteristics: injection, sexual party and psychostimulant drugs. The French Medical Agency requested a risk assessment of "SLAM" and more broadly of the use of psychostimulants in a sexual context, by the analysis of complications related to this practice notified to the French Network of Addictovigilance Centers. All cases of complications related to "SLAM" practice, including cases of abuse or dependence, and somatic and psychiatric complications, were analysed.
View Article and Find Full Text PDFFundam Clin Pharmacol
April 2016
Centre d'Addictovigilance, Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM, U657, Bordeaux, F-33000, France.
Parachuting (also called bombing) is a method of drug delivery where illicit drugs or medicines are ingested after wrapping the substance. There are little data describing parachuting in the literature. To provide a description of this practice, all cases of parachuting reported to the national addictovigilance network up to 31 December 2014 were identified from spontaneous reports and specific surveillance programs.
View Article and Find Full Text PDFEur J Clin Pharmacol
December 2015
Centre d'Addictovigilance, Hôpital Lapeyronie, Centre Hospitalier Régional Universitaire et Université de Montpellier, Montpellier, France.
Am J Emerg Med
November 2015
Regional Observatory of Emergency Medicine in Midi-Pyrénées (ORU-MiP), Purpan University Hospital, Toulouse, France.
Objectives: The objectives of this study are to describe an emergency department (ED) adult population with the chief complaint of mental and behavioral disorders due to psychoactive substance use and to investigate sex- and age-related differences.
Methods: We analyzed data (2009-2011) from the Regional Observatory of Emergency Medicine ORU-MiP (700000 patients per year) for all patients with a primary diagnosis of mental and behavioral disorders due to psychoactive substance use. Day data were weighted by the number of days in the year and expressed for 100000 inhabitants of the area.
Pharmacoepidemiol Drug Saf
September 2015
Aix Marseille Université, Institut de Neurosciences Timone, CNRS 7289, Service de Pharmacologie clinique et pharmacovigilance-, 264, rue Saint Pierre, 13385, Marseille, France.
Purpose: In pharmacoepidemiology, one of the main concerns is analysis of drug exposure time. However, in real-life settings, patient's behavior is complex and characterized by drug exposure dynamics. Multi-state models allow assessing the probabilities of various patterns, instead of just continuous use and/or discontinuation.
View Article and Find Full Text PDFTherapie
May 2015
Aix Marseille Université, Institut de Neurosciences Timone, CNRS 7289, Service de Pharmacologie Clinique et Pharmacovigilance, Marseille, France - Centre d'Addictovigilance (CEIP), PACA-Corse Marseille, Marseille, France.
Background: In France, methadone has historically been less accessible than buprenorphine. In 2008, a dry formulation (capsule) was introduced into the market, aimed in particular to improve methadone accessibility.
Objective: To describe the impact (prevalence of use, patient profiles and compliance with requirements) of the dry methadone formulation in France.
Therapie
May 2015
Pharmacoépidémiologie, UMR1027 INSERM - Université de Toulouse III, Toulouse, France.
The objective of this paper is to present an evaluation of the potential for abuse of and dependence on a drug from the data obtained from the different pharmacoepidemiological tools used by the French network for evaluation and information on pharmacodependence and addiction monitoring taking the example of tramadol. Comparison of the data from spontaneous reports with surveys in specific populations and with evaluations of indicators of diverted uses does not highlight a major problem of tramadol abuse and dependence in terms of public health, but stresses the importance of paying attention to the signal. This example of addiction monitoring of tramadol illustrates the interest of comparing results obtained from different validated sources.
View Article and Find Full Text PDFTherapie
May 2015
Centre d'Addictovigilance de Caen, CHU, Caen, France.
New substances, also known as "designer drugs" or "legal highs" are increasingly available to drug users. Two hundred and fifteen hitherto unlisted substances have been notified by European Union member states since 2005. These synthetic drugs, which have been developed to side-step the legislation on drugs, are analogues or derivatives of existing drugs and medications.
View Article and Find Full Text PDF